↓ Skip to main content

Dove Medical Press

OnabotulinumtoxinA for chronic migraine: a critical appraisal

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users
patent
2 patents

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
35 Mendeley
Title
OnabotulinumtoxinA for chronic migraine: a critical appraisal
Published in
Therapeutics and Clinical Risk Management, June 2015
DOI 10.2147/tcrm.s76964
Pubmed ID
Authors

Rubesh Gooriah, Fayyaz Ahmed

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 3%
Unknown 34 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 20%
Student > Master 6 17%
Student > Ph. D. Student 4 11%
Unspecified 3 9%
Researcher 3 9%
Other 6 17%
Unknown 6 17%
Readers by discipline Count As %
Medicine and Dentistry 13 37%
Unspecified 3 9%
Nursing and Health Professions 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Neuroscience 2 6%
Other 3 9%
Unknown 9 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2024.
All research outputs
#1,873,826
of 25,584,565 outputs
Outputs from Therapeutics and Clinical Risk Management
#76
of 1,308 outputs
Outputs of similar age
#23,264
of 281,752 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 43 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,308 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 281,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.